Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 53 points (-0.3%) at 16,478 as of Wednesday, Jan. 8, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,242 issues advancing vs. 1,672 declining with 178 unchanged. The Financial sector currently sits down 0.1% versus the S&P 500, which is unchanged. Top gainers within the sector include Royal Bank of Scotland Group (The ( RBS), up 2.8%, Nomura Holdings ( NMR), up 2.8%, Lloyds Banking Group ( LYG), up 2.5%, UBS ( UBS), up 2.3% and Deutsche Bank ( DB), up 2.2%. On the negative front, top decliners within the sector include Plum Creek Timber ( PCL), down 1.6%, Brookfield Asset Management ( BAM), down 1.6%, Weyerhaeuser ( WY), down 1.2%, IntercontinentalExchange Group ( ICE), down 1.1% and CME Group ( CME), down 1.0%. TheStreet would like to highlight 5 stocks pushing the sector higher today: 5. MetLife ( MET) is one of the companies pushing the Financial sector higher today. As of noon trading, MetLife is up $0.65 (1.2%) to $54.02 on light volume. Thus far, 2.1 million shares of MetLife exchanged hands as compared to its average daily volume of 5.7 million shares. The stock has ranged in price between $53.52-$54.13 after having opened the day at $53.83 as compared to the previous trading day's close of $53.37. MetLife, Inc., through its subsidiaries, provides insurance, annuities, and employee benefit programs in the United States, Japan, Latin America, the Middle East, Asia, and Europe. MetLife has a market cap of $60.1 billion and is part of the insurance industry. The company has a P/E ratio of 24.2, above the S&P 500 P/E ratio of 17.7. Shares are down 1.0% year to date as of the close of trading on Tuesday. Currently there are 14 analysts that rate MetLife a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates MetLife as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, impressive record of earnings per share growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full MetLife Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.